Member Info for Bebeto

I recall Shell & BP have priced in $50 a barrel, which would give us $30 a barrel profits near future term.

Correct 50/50 , it's in ordinal scale so there will be predefined measurement points and they will fill in how many at each point. This type of statistical analysis is conclusive and cannot be manipulated.

It will be life changing for Synairgen, if the trial is a success we're going to get snapped up pretty quickly.! SNG have spent all the money and thrown the kitchen sink at this for that very reason.

Couldn't resist just had a little top up , thanks guys

Should hear something regarding Jamaica soon, license runs out at the end of July.

I'm quite happy for the shareprice to remain at this level before news and let the traders to buy in ont the first pull back, on positive results.

The case for SNG not having the COPD results now is very weak with 6.5weeks after the approval RNS. Radio silence is deafening, I'm expecting hospital results next week combined with COPD results.

Locked loaded and ready.

The grains of sand in the results timer is getting low now. I'm confident the results will show a positive response to SNG001.

Today's drop looks a bit harsh but a lot of it is the spread being moved around, in the meantime UOG is still making a profit just like they will everyday. Looking forward to seeing the compound effect from all these profits.

I beg to differ, I bought into GGP after a 500% rise and under 3yrs later I'm very close to 2K% up, I've top sliced and now mortgage free, best tip on a forum ever for me.! I don't believe in investing lots of shares just a select few with massive potential just like SNG.

By my estimations there's only five sessions left before the hospital results some people think it's slightly longer but the results will be in ordinal scale. Ordinal scale is literally putting numbers in predefined boxes to maximize the statistical analysis of data.

The results will be the same as this because this is SNG001:

Treatment with inhaled interferon beta did however switch on the lungs' antiviral defences (as measured by blood levels of the antiviral biomarker CXCL10), have a beneficial effect on lung function (Morning Peak Expiratory Flow: difference of 19.7 litres per minute average over the first 7 days of treatment (p=0.01)), and was well tolerated. Effects on biomarkers, lung function and the good tolerability profile were consistent with the Company's own Phase II trial (SG005).

The study did not however meet AstraZeneca's predefined criteria for progression, and they have elected to return the rights to AZD9412 to Synairgen.

https://markets.ft.com/data/announce/full?dockey=1323-13206094-0G2UV3F6787OLFH4CT3HTRNKEJ

Yeah, they could pay for it in installments, say 6months free then APR 8M%

I'm actually starting to think Newcrest will take upto 75% of Havieron and no more because there's so much gold that they couldn't afford the other 25%.

Some of the 14M options being taken up? They'll be all churned in the run upto results, in time for the next move up.

Nolupus, I say 16th you say 20/21st splitting hairs but that's my estimate, I won't be disappointed if it's not right.

Looking forward to seeing the results, after reading the below RNS , from AZN failed P2 trial as the same drug as SNG001, I'm confident of a positive result it just depends upon what degree of positivity

https://markets.ft.com/data/announce/full?dockey=1323-13206094-0G2UV3F6787OLFH4CT3HTRNKEJ

Since my last post (the other day) UOG has made thousands in profits and will continue too, every day the shareprice will follow suit.

Newcrest keeps finding more gold at Havieron & GGP keeps finding more targets, then the shareprice will look after itself.

Roll on next update on 23rd July

There's only one Gold play on AIM, the rest are just pretenders.

The free float here is getting smaller, sooner or later the rise is coming before news.

If Newcrest or anyone else was to buy any of our projects, then they would hedge the gold price for the term of the mining length, in order to come up with a fair price.

Looking forward to seeing the MRE.